Operating Lease, Right-of-Use Asset of GYRE THERAPEUTICS, INC. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
GYRE THERAPEUTICS, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • GYRE THERAPEUTICS, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,300,000, a 34% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

GYRE THERAPEUTICS, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,300,000 -$684,000 -34% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $1,500,000 -$597,000 -28% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $1,600,000 +$1,241,000 +346% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $1,818,000 +$1,329,000 +272% 31 Dec 2024 10-K 17 Mar 2025 2024 FY
Q3 2024 $1,984,000 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $2,097,000 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $359,000 +$342,000 +2012% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $489,000 -$177,000 -27% 31 Dec 2023 10-K 17 Mar 2025 2024 FY
Q1 2023 $17,000 -$2,225,000 -99% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $666,000 -$2,078,000 -76% 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q3 2022 $481,000 -$2,132,000 -82% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $1,733,000 -$1,374,000 -44% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $2,242,000 +$596,000 +36% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $2,744,000 +$912,000 +50% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $2,613,000 +$1,089,000 +71% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $3,107,000 +$1,447,000 +87% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $1,646,000 -$149,000 -8.3% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $1,832,000 -$95,000 -4.9% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $1,524,000 -$534,000 -26% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $1,660,000 -$528,000 -24% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $1,795,000 -$520,000 -22% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $1,927,000 31 Dec 2019 10-K 04 Mar 2021 2020 FY
Q3 2019 $2,058,000 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $2,188,000 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $2,315,000 31 Mar 2019 10-Q 02 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.